יוקריאס 50/850 מ"ג

Land: Israel

Språk: hebraisk

Kilde: Ministry of Health

Aktiv ingrediens:

METFORMIN HYDROCHLORIDE 850 MG; VILDAGLIPTIN 50 MG

Tilgjengelig fra:

NOVARTIS PHARMA SERVICES AG

ATC-kode:

A10BA02

Legemiddelform:

FILM COATED TABLETS

Administreringsrute:

PER OS

Produsert av:

NOVARTIS PHARMA STEIN AG, SWITZERLAND

Terapeutisk gruppe:

METFORMIN

Indikasjoner:

Eucreas is indicated in the treatment of type 2 diabetes mellitus:• Eucreas is indicated in the treatment of type 2 diabetes patients who are unable to achieve sufficient glycemic control at their maximally tolerated dose of oral metformin alone or who are already treated with the combination of vildagliptin and metformin as separate tablets.• Eucreas is indicated in combination with a sulphonylurea (i.e. triple combination therapy) as an adjunct to diet and exercise in patients inadequately controlled with metformin and a sulphonylurea.• Eucreas is indicated in triple combination therapy with insulin as an adjunct to diet and exercise to improve glycaemic control in patients when insulin at a stable dose and metformin alone do not provide adequate glycaemic control.

Autorisasjon dato:

2010-07-01